AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Gyre Therapeutics, Inc.

$4.55 -$2.25 (-33.11%)
NASDAQ · 30 Oct 2026 20:00 UTC
Previous Close
$6.41
Day Range
$4.51$6.25
Year Range
$4.51$9.14
Market Cap
482.98M
AVG Volume
119.37K
Trailing/Forward PE
-22.9/-
PEG ratio
0.07
Dividend Yield
-
Next Earnings Date
2026-11-06
Primary Exchange
NASDAQUS
Revenue (USD) · TTM
050M100M150M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
GYRE Revenue (USD) by quarter, trailing twelve months
PeriodRevenue (USD)
26 Q2119.38M
26 Q1120.01M
25 Q4119.55M
25 Q3110.23M
25 Q2105.15M
25 Q1100.64M
24 Q4105.76M
24 Q3105.03M
24 Q2111.59M
24 Q1115.69M
Net Income (USD) · TTM
-100M-50M050M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
GYRE Net Income (USD) by quarter, trailing twelve months
PeriodNet Income (USD)
26 Q2-17.33M
26 Q1-6.13M
25 Q45.18M
25 Q36.81M
25 Q24.32M
25 Q17.25M
24 Q412.09M
24 Q3-88.82M
24 Q2-85.97M
24 Q1-87.64M
Operating Income (USD) · TTM
-100M-75M-50M-25M025M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
GYRE Operating Income (USD) by quarter, trailing twelve months
PeriodOperating Income (USD)
26 Q2-16.67M
26 Q1-4.55M
25 Q47.08M
25 Q37.55M
25 Q24.86M
25 Q110.37M
24 Q416.16M
24 Q3-76.07M
24 Q2-67.53M
24 Q1-65.82M
EBITDA · TTM
Cash Flows · TTM
EPS · TTM
Expenses · TTM
Cash & Debt · TTM
Debt ratios · TTM
Margins · TTM
Return on Capital · TTM
Shares Outstanding · TTM
Dividends (USD) · TTM
Employee Count
Book Value Per Share · TTM
Total Assets · TTM
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book

Earnings: GYRE

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 6 Nov 2026.

Gyre Therapeutics, Inc.
GYRE
Stockpicker

Video analysis: GYRE

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: GYRE

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.